NBSE

NeuBase Therapeutics, Inc. Common Stock

Delisted

NBSE was delisted on the 10th of May, 2024.

47 hedge funds and large institutions have $9.59M invested in NeuBase Therapeutics, Inc. Common Stock in 2015 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 14 increasing their positions, 15 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
47
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$50K
Puts
$1.06M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$2M
2
$1.08M
3
$1.02M
4
$603K
5
$566K
6
$410K
7
$352K
8
$296K
9
$258K
10
$239K
11
$217K
12
$189K
13
$184K
14
$167K
15
$155K
16
$147K
17
$145K
18
$143K
19
$130K
20
$113K
21
$105K
22
$94K
23
$91K
24
$87K
25
$80K